China has put Illumina on its ‘unreliable entity list’ after the US imposed sanctions on Beijing Genomics Institute, also a ...

Beijing’s action against clothing maker PVH and biotech company Illumina underlines risk created by trade tensions ...

Market OverviewThe Global Carrier Screening Market is a genetic testing process that determines whether an individual carries ...

Astellas is shifting its investment focus toward more established modalities and later-stage opportunities, its chief ...

Genomics is bringing in a new wave of money from an unlikely group of investors — health systems. More providers are ...

Illumina, Inc. (NASDAQ:ILMN – Get Free Report)’s share price reached a new 52-week low during mid-day trading on Wednesday after Morgan Stanley lowered their price target on the stock from $150.00 to ...

Through new partnerships with industry leaders, Nvidia aims to help advance practical use cases for AI in healthcare and life ...